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Background: Provision of clinically relevant information about complementary and alternative medicine (CAM) to
health care professionals is not well described. The aim of the study was to assess questions about CAM to the
Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS).
Methods: All question-answers pairs (QAPs) in the RELIS database indexed with alternative medicine from 2005-2010
constituted the study material. A randomly selected sample of 100 QAPs was characterized with regard to type of
question (category, patient-specific or general), occupation and workplace of enquirer, the type of information search
performed (simple or advanced), and if the answers contained information to provide factual or consultative replies
(facts about or advice on clinical use of CAM, respectively). Proportions were compared with Fisher’s exact test with
significance at the 0.05 level.
Results: One thousand and thirty-eight (7.7%) out of 13 482 questions involved CAM. Eighty-two out of 100 questions
concerned products containing one or more herbs, vitamins and minerals as well as other substances. Thirty-eight out
of 100 questions concerned the category documentation (substance identification and/or literature reports about
clinical effects), 36 interactions, 16 adverse effects, 9 pregnancy and lactation, and 1 question concerned
contraindications. Sixty-three questions were patient-specific and 37 general. Fifty-four questions came from
physicians, 33 from pharmacists and 13 from others (including nurses, midwives, students, CAM practitioners,
and the public). Pharmacists asked more frequently about interactions while physicians asked more frequently
about adverse effects (p < 0.05). Seventy-six of the questions came from outside hospital, mainly general practice and
community pharmacies. Fifty-nine answers were based on a simple and 41 on an advanced information search.
Thirty-three factual and 38 consultative answers were provided. In 29 answers, search provided no information. Lack
of information to provide an answer was not significantly different between patient-specific (31.7%) and general
questions (24.3%).
Conclusions: General practice and community pharmacies are the main sources for questions about CAM to RELIS.
Physicians are concerned about adverse effects while pharmacists are concerned about interactions. Lack of
information to provide answers to patient-specific and general questions about CAM represents a problem.
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RELIS is a network of four regional medicines informa-
tion and pharmacovigilance centres. The centres are local-
ised at university hospitals in Norway, where pharmacists
and clinical pharmacologists answer questions from health
care professionals (mainly physicians and pharmacists)
working in hospitals, hospital pharmacies, general practice
and community pharmacies [1].
During the last decade, the proportion of questions
involving complementary and alternative medicine (CAM)
to RELIS has been about 8%. In 2005, 151 questions
among 1876 involved CAM compared to 189 among 2420
in 2010. This reflects the use of this type of medicine both
for acute symptoms, but also chronic diseases among the
public. The working method in RELIS is to find evidence-
based information and relate it to the clinical setting and
individual characteristics of a patient (problem-oriented
drug information). Thus, questions from health care
professionals about CAM typically concern patients with
chronic diseases where alternative medicine is added to an
established drug therapy and decision support is requested.
An example of a typical question to RELIS concerned a
patient with ovarian cancer with liver metastases where
treatment with liposomal doxorubicin was planned. The
patient used CAM including Taraxacum officinale (dande-
lion), Curcuma longa (turmeric), and Silybum marianum
(milk thistle). The hospital physician asked if CAM inter-
acted with doxorubicin or interfered with the metastatic
cancer disease. Thus, questions to RELIS frequently repre-
sent the most complex drug-related clinical problems
where other drug information sources are either inconsist-
ent or insufficient to solve them. The time used to answer
questions about drugs in RELIS is dependent on the type
of literature search that has to be performed [2]. Availabil-
ity of high quality evidence-based databases is of major im-
portance to facilitate literature searches, and this is also of
importance regarding questions about CAM [3,4].
The growing interest for CAM in the public [5] is also
reflected in the conventional health care system, which
RELIS serve. CAM is presently offered in about 50% of
Norwegian hospitals compared to one-third of Danish
hospitals [6]. Furthermore, a high percentage of herbal co-
use among patients using conventional drugs in general
practice has been shown in a Norwegian study. In this
study, three out of four patients did not discuss herbal use
with any health care professional [7]. An Australian study
found that the current lack of knowledge about CAM
among general practitioners (GPs) hampered communica-
tion with patients [8]. Education and information needs
among both health care students and professionals con-
cerning CAM have been reported in European studies
as well [9,10]. Our experience with queries about CAM
to RELIS in Norway supports this perception. The ques-
tions often include statements that the enquirer needsinformation and advice due to lack of knowledge and
competence about the subject.
We found sparse documentation of problem-oriented
drug information and need of decision support associated
with CAM in the literature, and believe the present pilot
study could identify some challenges and areas of im-
provement for medicines (or drug) information centres.
Methods
Question-answer pairs (QAPs)
The RELIS database is a full-text, QAP database shared
by RELIS where QAPs from each region of Norway are
indexed and published to be searchable (in Norwegian)
for health care professionals free of charge [1]. All QAPs
in the RELIS database indexed with alternative medicine
(the term for CAM) from 2005-2010 constituted the
study material. A randomly selected sample of 100 QAPs
was collected with use of Research Randomizer (www.
randomizer.org). Demographics of each enquirer (occu-
pation, workplace) are registered in the database. Fur-
thermore, data is recorded on whether the question is
general or patient-specific, and if it concerns mainly an
interaction, adverse effects, pregnancy, documentation
or other predefined categories. The category documenta-
tion involves questions about substance identification
and/or literature reports about clinical effects. The drugs
involved in a QAP are registered according to their gen-
eric name, trade name and ATC-number according to
the Anatomical Therapeutic Chemical (ATC) classifica-
tion developed by the World Health Organization [11].
The text and references in each QAP was examined by
HE. In case of any questions about classification, JS was
consulted for a final agreement.
Analysis of the questions
The questions were characterized with regard to type of
category (e.g. adverse effects, interactions, pregnancy),
occupation and workplace of enquirer, if the questions
were patient-specific (concerned a particular patient) or
general (concerned guidelines for clinical practice or a
population of patients or based on academic interest). In
addition the number and category of CAM, and number
of drugs in the questions were described.
Analysis of the answers
The type of information search performed was based on
the type of references and description of search strategy
in the text of the answers. Categories of information
search were based on a previous publication from RELIS
[2]. If it was necessary to search the RELIS database, da-
tabases containing monographs like the Micromedex, the
summary of product characteristics (SPC) for the drug,
Natural Medicines Comprehensive Database, Stockley’s
Herbal Medicines Interactions, reference books and/or
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was categorised as simple. If searches in databases like
Medline, Embase or Cochrane to obtain original articles
were necessary or additional information was needed or
not available as a result of an extensive the search, the
search was categorised as advanced. The answers were
characterized with regard to if they contained information
to provide factual or consultative replies according to a
definition by Davies et al. [12]. Factual answers, such as
the therapeutic dose of a drug (or substance) or its half-
life, or synonyms for traditional herbal medicines, can
usually be located in textbooks, monographs or databases.
Answers that included clinical advice on a specific case
and entailed communication with a health care profes-
sional on the possible benefits and hazards of one or more
courses of action were called consultative.
Statistics
The data were analysed using SPSS 17.0 (SPSS Inc., Chicago
IL). The Fisher’s exact test was applied when comparing
categorical variables. To account for multiple compari-
sons (z-test), the significance level was adjusted using
the Bonferroni method. P values < 0.05 were considered
significant.
Results
Analysis of the questions
In the period from 2005-2010, RELIS received a total
of 13 482 questions, where 1038 (7.7%) involved
CAM. Fifty-four out of 100 enquirers were physicians,
33 pharmacists and 13 others (including nurses, midwives,
students, CAM practitioners and the public) (Table 1).
Thirty-five physicians were general practitioners, 3 worked
in private practice and 16 in hospital. Twenty-five pharma-
cists worked in community pharmacies, 7 in hospital phar-
macies and 1 in another type of institution. Nine questions
concerned herbal medicines, 5 vitamins and minerals, 68
natural medicines with several ingredients including herbs,
vitamins and minerals as well as other substances, and 7
were categorized as others (e.g. homeopathy, acupuncture,Table 1 Occupation and workplace of enquirers (N = 100) abo
Workpl
Occupation General practice
(N = 36) fraction %
Hospital
(N = 17) fraction %
Commun
pharma
(N = 26) frac
Physicians (N = 54) 35/54 64.8 16/54 29.6
Pharmacists (N=33) 25/33 75
Midwifes (N = 3)
Nurses (N = 2) 1/2 50.0 1/2 50.0
Other (N = 8)a 1/8 12.
CAM = Complementary and alternative medicine; RELIS = Regional Medicines Inform
aIncluding 1 pharmacy student, 1 acupuncturist, 1 homeopath, 1 employed in publ
bIncluding private practice for physicians and CAM practitioners, and community prand alkaline water). Eleven questions concerned questions
about two (n = 9) or three (n = 2) concomitant categories
of CAM. The number of substances in the questions
ranged between 1 and 21, sixty-five concerned one sub-
stance, 12 two, and 23 three or more. The number of drugs
in the questions ranged between 0 and 10. Fifty-two con-
cerned no drug, 25 one, 7 two, and 16 three or more. The
three most common categories of questions concerned
documentation (n = 38), interactions (n = 36) and adverse
effects (n = 19), while 9 concerned pregnancy and lacta-
tion and 1 contraindications. Sixty-three questions were
patient-specific while 37 were categorised to be more gen-
eral. There were no significant differences between the
two major occupations physicians and pharmacists with
regard to category of CAM, number of substances or
drugs in the questions. Seventy-six of the questions came
from outside hospital and hospital pharmacies (mainly
from general practice or community pharmacies). Patient-
specific questions were more frequent than general ques-
tions in hospitals, and among physicians (all compari-
sons, p < 0.05). Table 2 shows that pharmacists asked
more frequently about interactions while physicians asked
more frequently about adverse effects (all comparisons,
p < 0.05).
Analysis of the answers
While monographs and databases were cited in 59 of the
answers (simple search) advanced search strategies was
used in 41. Three answers did not have references.
Table 3 shows simple or advanced search strategies ac-
cording to references or text in the 100 answers. Table 4
shows if the answers contained information to provide
consultative or factual replies to 100 patient-specific or
general questions. Lack of information was found in
24.3% of the answers to general questions and in 31.7%
of the answers to patient-specific questions. The corre-
sponding figures (lack of information) were 31.2% for
adverse effects, 33.3% for pregnancy and breastfeeding,
and one answer to the single question about contraindi-
cations (100%). Answers to questions about interactionsut CAM to RELIS
ace
ity
cy
tion %
Hospital pharmacy
(N = 7) fraction %
Private or
community practice
(N = 8)b fraction %
Other
(N = 6) fraction %
3/54 5.6
.8 7/33 21.2 1/33 3.0
3/3 100.0
5 2/8 25.0 5/8 62.5
ation and Pharmacovigilance Centres in Norway.
ic child care, and 4 public requests (patient or private person).
actice for midwifes.
Table 2 Category of questions by occupation (N = 100) about CAM to RELIS
Category
Occupation Documentation
(N = 38) fraction %
Interactions
(N = 36) fraction %
Adverse effects
(N = 16) fraction %
Pregnancy and breastfeeding
(N = 9) fraction %
Contraindications
(N = 1) fraction %
Physicians (N = 54) 23/54 42.6 15/54 27.8 12/54 22.2* 3/54 5.6 1/54 1.9
Pharmacists (N = 33) 10/33 30.3 20/33 60.6** 1/33 3.0 2/33 6.1
Midwifes (N = 3) 3/3 100.0
Nurses (N = 2) 1/2 50.0 1/2 50.0
Other (N = 8)a 4/8 50.0 1/8 12.5 3/8 37.5
CAM = Complementary and alternative medicine; RELIS = Regional Medicines Information and Pharmacovigilance Centres in Norway.
aIncluding 1 pharmacy student, 1 acupuncturist, 1 homeopath, 1 employed in public child care, and 4 public requests (patient or private person).
*Significantly more questions among physicians compared to pharmacists, p < 0.05.
**Significantly more questions among pharmacists compared to physicians, p < 0.05.
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answers to questions about documentation (44.4% versus
10.5%, p < 0.05). There were no significant differences
between the two major occupations physicians and phar-
macists with regard to search strategies or information
found to provide answers.
Discussion
General practice and community pharmacies are the
main sources for questions about CAM to RELIS. This
is not surprising since everyone who is resident in a
Norwegian municipality is entitled to be registered as a
patient with a general practitioner (GP). Drugs prescribed
by these GPs are usually provided by local pharmacies.
Both GPs and pharmacists are common resources in the
primary health care system to discuss CAM with the
patients.
Physicians are concerned about adverse effects while
pharmacists are concerned about interactions according
to our results. We speculate if this could be explained by
the different roles of the respective occupations. Physi-
cians focus mainly on diagnosis and treatment of exist-
ing diseases and prevention of new when patients use
CAM. All questions concerning adverse effects from phy-
sicians (n = 12) were all based on symptoms and clinical
observations in patients. The questions concerned effects
on internal organs (kidney, liver), abnormal laboratory
values (liver enzymes, creatinine, sodium, ferritin, choles-
terol) and specific central nervous (syncope, seizures),
skin (flushing, bruises, hematomas) and gastrointestinal
(stomach pain) symptoms. Pharmacists focus on potentialTable 3 Search strategy and references in answers to questio
Simple searcha (N = 59)
Previous answers from the
RELIS database fraction %
Monographs and
databases fraction %
13/59 22.0 46/59 78.0
CAM = Complementary and alternative medicine; RELIS = Regional Medicines Inform
aSimple search includes the RELIS database, databases containing monographs like
product characteristics (SPC) for a drug, Natural Medicines Comprehensive Databas
bAdvanced search include databases like Medline, Embase or Cochrane to obtain ointeractions with drugs. They are familiar with drug inter-
action alert systems in the pharmacies to check prescriptions
and communicate about this to patients and physicians [13].
A Canadian study found that both consumers and pharma-
cists thought pharmacists should be knowledgeable about
natural health products and able to manage possible drug
interactions. Pharmacists in the study tended to place an
emphasis on ensuring patient safety, especially with respect
to potential interactions with natural health products, as
their first priority in patient care [14]. In our results ques-
tions about interactions frequently involved drugs with low
therapeutic index known to be sensitive to interactions like
warfarin and lithium as well as interactions involving other
cardiovascular and psychotropic drugs.
About 30% of the 100 answers lacked relevant informa-
tion to provide factual or consultative replies irrespective
if they were patient-specific or general. Questions about
documentation of effect and benefit of CAM were the
most frequent, and also the category with the highest pro-
portion of answers where relevant information was found
(excluding questions about contraindications). Lack of in-
formation in answers to questions about interactions re-
flects the general lack of safety data associated with CAM
[15,16]. Although potential benefits of CAM are fre-
quently described in monographs, lack of systematic stud-
ies of CAM-drug interactions, in particular for CAM not
classified as drugs by the Norwegian Medicines Agency,
represent a challenge. The finding that 22% of advanced
searches did not retrieve relevant references supports this
notion. Relevant references do not include in vitro data,
animal studies and retrospective clinical data like casens (N = 100) about CAM to RELIS
Advanced searchb (N = 41)
Original articles
fraction %
Additional information needed
or not available fraction %
32/41 78.0 9/41 22.0
ation and Pharmacovigilance Centres in Norway.
the Micromedex,Stockley’s Herbal Medicines Interactions, the summary of
e, reference books and/or colleagues/other health care professionals only.
riginal articles if necessary or additional information needed or not available.
Table 4 Information in the answers to questions (N = 100) about CAM to RELIS
General questions (N = 37)a Patient-specific questions (N = 63)b
Information
available for
factual answersc
fraction %
Information
available for
consultative answersd
fraction %
No information available
for either factual or
consultative answers
fraction %
Information
available for
factual answersc
fraction %
Information
available for
consultative answersd
fraction %
No information available
for either factual or
consultative answers
fraction %
21/37 56.8* 7/37 18.9 9/37 24.3 12/63 19.0 31/63 49.2** 20/63 31.7
CAM = Complementary and alternative medicine; RELIS = Regional Medicines Information and Pharmacovigilance Centres in Norway.
*Significantly more among general questions, p < 0.05.
**Significantly more among patient-specific questions, p < 0.05.
aGeneral questions concern guidelines for clinical practice or a population of patients or based on academic interest.
bPatient-specific question concerned a particular patient.
cAnswers like the therapeutic dose of a drug or its half-life or synonyms for traditional herbal medicines which can usually be located in textbooks, monographs
or databases.
dAnswers that included clinical advice on a specific case and entails communication with a health care professional on the possible benefits and hazards of one or
more courses of action.
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generalised to clinical practice.
RELIS include a staff of pharmacists and clinical phar-
macologists with training and expertise in literature
search and with access to several reference databases [1].
A high proportion of questions to RELIS requires con-
sultative replies, and the competence among the staff and
access to several literature sources makes us a valued pro-
vider of drug information according to evaluation studies
of our service [17,18]. Lack of available relevant informa-
tion in the case of questions about CAM represents how-
ever a medicines information problem, and given the high
proportion of patient-specific questions also clinically rele-
vant safety problem. Furthermore, questions about CAM
could increase the time spent handling a query, as exten-
sive literature searches may have to be done to make sure
no information is overlooked [2].
There were few questions about pregnancy and breast-
feeding while this represents about 19% of questions to
RELIS concerning drugs. Others have found that many
pregnant women use CAM, but do not discuss this with
health care professionals. In a study from UK more than
75% of 334 pregnant women did not discuss use of CAM
with their physicians or midwives [19]. Furthermore, in a
Norwegian study including 600 pregnant women with
about 40% using herbal drugs, 8 of 10 women did this
based on recommendations from persons other than
health care personnel [20]. This could in part be related to
the lack of safety information in CAM products over the
counter in pharmacies or available from other sources
[21]. Lack of safety information could be perceived as
“without any risk” by pregnant and breastfeeding women,
and reduce the motivation for discussions about safety
with health care professionals and thereby RELIS.
Limitations
This represent a pilot study with a randomly selected
sample of 100 QAPs from the RELIS database, about 10%
of all QAPs about CAM received in the study period. Dur-
ing the last decade, the proportion of questions involvingcomplementary and alternative medicine (CAM) to RELIS
has been about 8%. In 2011, 177 questions (7%) among 2565
involved CAM compared to 157 questions (6%) among 2586
in 2012. There is no reason to believe that variables con-
nected to questions or respective answers in these two
years are any different from previous years. Furthermore,
a randomly selected sample across a six year period
(2005-10) was used in the study to reduce the impact of a
single year.
The enquirers represent a selected group of health
care professionals, and may not be representative of the
general population of their respective occupations. Most
questions about CAM are probably not forwarded to
health professionals, some are handled by health care
professionals themselves, and a limited number of these
are forwarded to RELIS. The failure of patients to dis-
cuss use of CAM with health care professionals further
limits the number and variation of questions we receive.
Thus, the results cannot be used to assess frequency of
questions about or problems associated with use of
CAM. However, they can be used to describe the type of
questions submitted by health care professionals. Im-
portantly, the results reflect our experience with how re-
source demanding questions about CAM can be. This is
based on frequent lack of relevant scientific information,
a large number of substances in several questions, and a
large proportion of patient-specific questions with com-
plex clinical problems. Notice, that in this study, we did
not assess the actual advice in each answer, but the in-
formation found which could be used to provide it. In
RELIS, the staff usually gives advice although no relevant
information is found. An example is lack of any safety
information in the case of use of CAM during pregnancy
where caution is advised.
Future research
Lack of relevant information to provide answers to ques-
tions about CAM represents a particular problem accord-
ing to our results. A recent study conducted an online
search of 13 common herbals with regard to clinical
Schjøtt and Erdal BMC Complementary and Alternative Medicine 2014, 14:56 Page 6 of 6
http://www.biomedcentral.com/1472-6882/14/56claims, warnings, and other safety information [22]. Less
than 3% of 1179 Web sites cited scientific literature to ac-
company their claims, and this hampers the possibility for
clinical decision support. Future studies should assess
more in detail the type of questions RELIS and other med-
icines information centres receive. Furthermore, it would
be of great interest to know the implications in clinical
practice for the enquirer who has to make a decision.
Conclusions
This study showed that physicians and pharmacists in
general practice and community pharmacies are the
main sources for questions about CAM to RELIS. Physi-
cians are concerned about adverse effects while pharma-
cists are concerned about interactions. The motivation
to contact RELIS was based on clinically relevant symp-
toms and diagnostic observations as well as use of poten-
tially toxic drugs sensitive to interactions. Lack of relevant
information to provide answers represents a problem, in
particular with regard to the high proportion of complex
patient-specific questions to RELIS.
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